Showing 461 - 480 results of 10,572 for search '"tumors"', query time: 0.09s Refine Results
  1. 461

    Adrenal Rest Tumor of the Liver Preoperatively Diagnosed as Hepatocellular Carcinoma by Megumu Enjoji, Katsuya Sanada, Ryota Seki, Takashi Ito, Masato Maeda

    Published 2017-01-01
    “…Hepatic adrenal rest tumors are rare and show similar findings to hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  2. 462

    Treatment Choices for Tenosynovial Giant Cell Tumor: Surgery or Observation? by Hairong XU, Jing CHEN, Xiaohui NIU

    Published 2025-01-01
    Subjects: “…tenosynovial giant cell tumor…”
    Get full text
    Article
  3. 463

    Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma by Zeynep Kacar, Eric Slud, Doron Levy, Julián Candia, Anuradha Budhu, Marshonna Forgues, Xiaolin Wu, Arati Raziuddin, Bao Tran, Jyoti Shetty, Yotsawat Pomyen, Jittiporn Chaisaingmongkol, Siritida Rabibhadana, Benjarath Pupacdi, Vajarabhongsa Bhudhisawasdi, Nirush Lertprasertsuke, Chirayu Auewarakul, Suleeporn Sangrajrang, Chulabhorn Mahidol, Mathuros Ruchirawat, Xin Wei Wang

    Published 2024-03-01
    “…Abstract Hepatocellular carcinoma (HCC) is a molecularly heterogeneous solid malignancy, and its fitness may be shaped by how its tumor cells evolve. However, ability to monitor tumor cell evolution is hampered by the presence of numerous passenger mutations that do not provide any biological consequences. …”
    Get full text
    Article
  4. 464
  5. 465

    Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential by Lulu Wang MD, PhD, Amyn A. Habib MD, Akiva Mintz MD, PhD, King C. Li MD, Dawen Zhao MD, PhD

    Published 2017-05-01
    “…However, this PS asymmetry is found disruptive in many tumor vascular endothelial cells. We discuss the underlying mechanisms for PS asymmetry maintenance in normal cells and its loss in tumor cells. …”
    Get full text
    Article
  6. 466

    Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma by JinSong Li, GuanBo Zhang, Gang Li, Jie Zhang, Zhi Yang, Lin Yang, ShiJie Jiang, JiaXing Wang

    Published 2025-02-01
    “…However, acquired resistance and the tumor immunosuppressive microenvironment (TIME) significantly hinder its clinical application. …”
    Get full text
    Article
  7. 467

    The Role and Therapeutic Potential of Endothelial Progenitor Cells in Tumor Neovascularization by Branislava Janic, Ali S. Arbab

    Published 2010-01-01
    “…Although the cellular and molecular mechanisms of tumor growth and metastasis are not completely understood, it is established that formation and growth of new blood vessels is a conditio sine qua non for tumor survival, growth, and expansion. …”
    Get full text
    Article
  8. 468

    Endometrioid Paraovarian Borderline Cystic Tumor in an Infant with Proteus Syndrome by Liliana Vasquez, Mariela Tello, Ivan Maza, Monica Oscanoa, Milagros Dueñas, Haydee Castro, Alan Latorre

    Published 2015-01-01
    “…Ovarian and paraovarian neoplasms are uncommon in children, mainly originating from germ cell tumors and, least frequently, epithelial tumors. There is an association between genital tract tumors and Proteus syndrome, a rare, sporadic, and progressive entity, characterized by a postnatal overgrowth in several tissues caused by a mosaic mutation in the AKT1 gene. …”
    Get full text
    Article
  9. 469

    Nongenetic evolution of the tumor: from challenges to new therapeutic opportunities by Elisa Oricchio

    Published 2025-01-01
    “…Indeed, several cell‐intrinsic and cell‐extrinsic mechanisms contribute to tumor evolution. In this viewpoint, I focus on how chromatin, epigenetic, and transcriptional changes contribute to tumor evolution, allowing cancer cells to transition to different cell states and bypass response to therapies. …”
    Get full text
    Article
  10. 470
  11. 471

    Imaging of CD47 Expression in Xenograft and Allograft Tumor Models by Alexander Zheleznyak, Oluwatayo F. Ikotun, Julie Dimitry, William A. Frazier, Suzanne E. Lapi

    Published 2013-11-01
    “…CD47 has been shown to be overexpressed by various tumor types as a means of escaping the antitumor immune response. …”
    Get full text
    Article
  12. 472

    Electrical impedance-based tissue classification for bladder tumor differentiation by Carina Veil, Franziska Krauß, Bastian Amend, Falko Fend, Oliver Sawodny

    Published 2025-01-01
    “…With bladder cancer, an important issue is tumor recurrence because of failure to remove the entire tumor. …”
    Get full text
    Article
  13. 473
  14. 474

    Conventional Chemotherapy and Inflammation: What Is the Role of the Inflammasome in the Tumor Microenvironment? by Chiara Colarusso, Michela Terlizzi, Simone Di Caprio, Anna Falanga, Emmanuel D’Andria, Roberta d’Emmanuele di Villa Bianca, Rosalinda Sorrentino

    Published 2025-01-01
    “…While the inflammatory process can facilitate tumor establishment and progression, on the other hand, current clinical approaches aim to boost the immune system against the tumor mass. …”
    Get full text
    Article
  15. 475

    An Extrafollicular Adenomatoid Odontogenic Tumor Mimicking a Periapical Cyst by Farzaneh Mosavat, Roxana Rashtchian, Negar Zeini, Daryoush Goodarzi Pour, Shabnam Mohammed Charlie, Nazanin Mahdavi

    Published 2018-01-01
    “…Adenomatoid odontogenic tumor (AOT) is a rare noninvasive odontogenic tumor that occurs mostly in the second decade of life. …”
    Get full text
    Article
  16. 476

    Urachal Tumor: A Case Report of an Extremely Rare Carcinoma by José Palla Garcia, Rita Sampaio, Carlos Peixoto

    Published 2017-01-01
    “…The urachus carcinoma is an extremely rare tumor that accounts for <1% of all bladder cancers. …”
    Get full text
    Article
  17. 477

    Two Patients with Extremely Elevated Tumor Markers: Where Is the Malignancy? by Patrick P. J. van der Veek, Wouter H. de Vos tot Nederveen Cappel, Alexandra M. J. Langers, Bart van Hoek

    Published 2011-01-01
    “…Serum tumor markers are useful to evaluate a cancer's response to treatment, for early detection of cancer relapse, and, in some cases, to diagnose malignancy. …”
    Get full text
    Article
  18. 478
  19. 479
  20. 480

    Eight patients with inflammatory myofibroblastic tumor treated with rigid bronchoscopy by Byeong-Ho Jeong, Rong Lih Ho, Ho Yun Lee, Joungho Han, Hojoong Kim

    Published 2025-01-01
    Subjects: “…Endobronchial inflammatory myofibroblastic tumor…”
    Get full text
    Article